Personal Cash Advance Guides Users to Best Loan Options

Lending resource PersonalCashAdvance.com has released a brand new guide centered on finding the best short-term loan options.

2011-08-31

WILMINGTON, DE, August 31, 2011 (Press-News.org) The US economy continues to produce conflicting headlines and consumer anxiety on a daily basis as unemployment remains above 9 percent. Those looking for a short-term financial solution routinely turn to online lending resources such as Personal Cash Advance, which promotes best loan options such as secure cash advances, payday loans, and other personal loans.

"Our new guide to finding the best loans has been met with much enthusiasm from consumers as the economy continues to heal," PersonalCashAdvance.com company spokesperson Neil Cutting said. "As a neutral source, we have the customer's best interest in mind when it comes to locating the most reputable lenders."

The site lists questions to ask potential lenders, as well as a run-through on how the online personal loan process works. Cutting emphasized that payday loan myths are debunked in the informative guide that is aimed at equipping consumers with facts.

"Personal Cash Advance provides a completely free and secure service, which sets it apart from other sources in terms of convenience," Cutting said. "We take pride in providing answers to questions in an expedient manner."

Personal Cash Advance is committed to assisting consumers find the best personal loan in a secure and timely manner. For more information, please contact 1-800-920-7430 or visit: http://www.personalcashadvance.com.

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

Faulty signaling in brain increases craving for sugar and drugs

2011-08-31

"Our data indicate that the brain becomes hypersensitive to rewards when this co-signaling of glutamate and dopamine does not function. Lower doses than normal are enough to increase the propensity to ingest the substance, and this is true of both sugar and cocaine," says Åsa Mackenzie, associate professor of neuroscience at Uppsala University and the researcher who led the study. Addiction disorders are a major social problem, and we lack sufficient knowledge of how they arise and how various substances impact the brain. The brain's reward system gives us feelings of ...

Hemodynamic results after Transcatheter Aortic Valve Implantation (TAVI)

2011-08-31

Since 2007 Transcatheter Aortic Valve Implantation (TAVI) has become an alternative treatment for elderly patients with severe aortic stenosis at high risk for surgical aortic valve replacement. At present, durability and hemodynamic performance of transcatheter aortic valves remain unclear. Our single center data of the German Heart Center in Munich demonstrates a sustained improvement of hemodynamic performance up to 3 years after CoreValve implantation. Aortic valve stenosis (AS) is the most frequent heart valve disease in Europe and North America. The most common ...

Optimal reperfusion in ST-elevation myocardial infarction

2011-08-31

Primary PCI is the best reperfusion therapy for patients presenting with acute ST-elevation myocardial infarction. CJ Terkelsen and co-workers used the Western Denmark Heart Registry to describe the implementation of primary PCI in Denmark. Their study (including almost 10,000 patients) showed that a strategy with early diagnosis based on ECG recording in the ambulance and directing the patients straight to the catherization laboratory in the Primary PCI Centre, was associated with a lower mortality. Direct access to PPCI is unfortunately still not possible in many European ...

Considerably lower risk of stent thrombosis and restenosis in 'new generation' drug-eluting stents

2011-08-31

Results from the SCAAR study, presented at the ESC Congress 2011 today, showed that Percutaneous Coronary Intervention (PCI) with "new generation" Drug Eluting Stents, was associated with a 38% lower risk of clinically meaningful restenosis and a 50% lower risk of stent thrombosis compared to old generation DES. Although many trials and studies support the overall early and mid-term safety and efficacy of first-generation drug-eluting stents, there has been concern on their long-term safety, especially regarding the potential risk of late stent thrombosis as well as ...

Cesis, Latvia - Summer 2011 - Christopher Flach, Filmmaker and Artist is Featured in the 2011 Cesis Festival

2011-08-31

With a great response from the audience Christopher Flach's film Madeleine Castaing, ended the last days of the Cesis Festival along with the final concert "Imants Kalnins and Philip Glass." Attended by more than 1800 visitors, this years 2011Festival contained a rich program featuring a diverse range of art forms included classical music concerts, visual art exhibitions, films and drama performances. Christopher Flach's film "Madeleine Castaing," is the documentary that explores the personality and influence of the French decorator and antique dealer. ...

Cardiac disease: Coronary or not?

2011-08-31

Acute myocardial Infarction (AMI) is a major cause of death and disability. Worldwide, one in eight patients die of an ischemic heart disease. Its rapid and accurate diagnosis is critical for the initiation of effective evidence based medical management, including early revascularization, but is still an unmet clinical need. The gradual implementation of high-sensitive cardiac troponins (hs-cTnT) in clinical practice has helped clinicians to detect and treat patients with acute myocardial infarction earlier than with conventional assays. But, high-sensitive assays have ...

Lower achieved platelet reactivity associated with better cardiovascular

2011-08-31

Compared to patients who had persistently high platelet reactivity, those who achieved low platelet reactivity, according to the VerifyNow P2Y12 Test, had a reduced incidence of cardiovascular death, heart attack and stent thrombosis, as indicated by a clinical trial presented today at the ESC Congress 2011. These findings were part of a secondary analysis of the Gauging Responsiveness with A VerifyNow P2Y12 Assay- Impact on Thrombosis and Safety (GRAVITAS) trial, the largest prospective trial to date to test the clinical efficacy of antiplatelet therapy modification, ...

Registry: Do medications which reduce angina

2011-08-31

Although medication which decreases the risk of angina attacks (chest pain caused by blockage of the arteries that supply the heart), are frequently prescribed in patients who have sustained a myocardial infarction, the possible influence of medication on long-term survival is not known, with the exception of beta-blocking agents, which have been shown to decrease mortality in clinical trials performed 30 years ago. Because antianginal drugs also protect the myocardium against ischemia (insufficient oxygen delivery to the heart muscle), there is a possibility that they ...

Transcatheter aortic valve implantation with the Edwards valve prosthesis in patients with low

2011-08-31

Results from a study presented today at the ESC Congress 2011, show that TAVI implantation in low risk patients, met with 100% procedural success (versus 95.3% in the high Euroscore group (p=0.1). "The most interesting point to observe is the absence of death at one month in the low Euroscore group, versus a mortality rate of 11.1% in the high Euroscore group (>20%), (p < 0.04) and this result is confirmed at 1-year with 5 vs 24.8 %, (p END ...

What do patients receiving optimal medical therapy after a heart attack die from?

2011-08-31

Because of improved management at the acute stage, the risk of dying in hospital after a heart attack has decreased by about 50% in the past 10 years. Likewise, the prescription of recommended medications when patients leave hospital, has resulted in improved survival and fewer recurrent heart attacks. One of the challenges is now to try and further decrease long-term mortality in patients who leave the hospital on "optimal" medical therapy (i.e. who are prescribed all the recommended medications). The French registry of Acute ST-elevation and non-ST-elevation Myocardial ...

LAST 30 PRESS RELEASES:

New study shows biochar’s electrical properties can influence rice field methane emissions

Guangdong faces largest chikungunya outbreak on record

Tirzepatide improves blood sugar control in children aged 10-17 years with type 2 diabetes inadequately controlled on existing therapies (SURPASS-PEDS trial)